Company: INSP
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001609550-25-000009
Chunk: 1

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01. Regulation FD Disclosure.

In February and March of 2025, the Company will be participating in various meetings with investors and analysts, and a copy of the Company’s presentation materials being used at these meetings is furnished as Exhibit 99.2 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company’s website at https://investors. inspiresleep. com.

The information in each of Item 2.02 and Item 7.01 of this Current Report on Form 8-K and in the press release attached as Exhibit 99.1 and the presentation attached as Exhibit 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.